Future Medicinal Chemistry

Papers
(The H4-Index of Future Medicinal Chemistry is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-07-01 to 2026-07-01.)
ArticleCitations
The role of descriptors extracted from ligand-target interaction to improve conventional QSAR model performance in the realm of angiogenesis receptor modulation to fight cancer66
The Connection Between PARP14 and SARS-CoV-263
Investigations of New N 1 -Substituted Pyrazoles as Anti-Inflammatory and Analgesic Agents having COX Inhibitory Act60
Development of 5-hydroxybenzothiophene derivatives as multi-kinase inhibitors with potential anti-cancer activity50
Novel Set of Highly Substituted Bis-Pyridines: Synthesis, Molecular Docking and Drug-Resistant Antibacterial Profile42
α-Glucosidase-targeting 1,2,4-triazole antidiabetic candidates: comparative analysis and future perspectives38
In vivo evaluation of novel synthetic pyrazolones as CDK9 inhibitors with enhanced pharmacokinetic properties32
Design and synthesis of new nicotinamides as immunomodulatory VEGFR-2 inhibitors and apoptosis inducers30
Biological and computational evaluation of novel benzofuranyl derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors29
Butenolide-based human carbonic anhydrase (hCA) I/II inhibitors: integrated computational and biological evaluation29
Therapeutic potential of spirocyclopropyl oxindoles: latest developments in drug discovery28
Small molecule dual inhibitors of HDAC6/HSP90 as potential anticancer therapeutics: an overview of design rationality and structure activity relationships26
Hybridization of isatin and benzoxazolinone via a diethyl spacer: a new scaffold for breast cancer drug discovery25
Recent advances in the design and development of small-molecule MMP-2 inhibitors24
Basic nitrogen (BaN): a ‘privileged element’ in medicinal chemistry24
Small-molecule Cathepsin K inhibitors: a medicinal chemistry perspective24
Synergistic effect of new pyrimidine derivative with oxacilin against methicillin-resistant Staphylococcus aureus24
Synthesis, antimicrobial evaluation, HPLC-based compound accumulation and docking studies of 2-methoxybenzoyl thioureas23
Wogonin-derived chemotype enables discovery of novel GLS1 inhibitors with potent antitumor activity22
Advances in AR-Targeting Chimeras: A Case Study of proteolysis-targeting Chimeras From Bench to Bedside22
Key heterocyclic moieties for the next five years of drug discovery and development22
New pyrrolopyridine-based Thiazolotriazoles As Diabetics Inhibitors: Enzymatic Kinetics and In Silico Study22
0.17722320556641